Quality-constant “prices” for the ongoing treatment of schizophrenia: an exploratory study

Abel, J. R., Berndt, E. R., & White, A. G. (2003, June). Price indexes for microsoft’s personal computer software products, 1993–2001. Unpublished manuscript, Analysis Group, Inc, Boston, MA. Alegria, 2003, The role of public policies in reducing mental health status disparities for people of color, Health Affairs, 22, 51, 10.1377/hlthaff.22.5.51 Allen, R. G. D. (1975). Index numbers in theory and practice. Chicago: Aldine Publishing Company. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, fourth edition. Washington DC. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV-TR). Washington, DC: American Psychiatric Association. Berndt, E. R. (2002, May 23). Trends and drivers of expenditures on psychotropic drugs in the U.S. Presentation at the National Institute of Mental Health Pharmacoeconomics Research Workshop, Bethesda, MD. Berndt, 2002, The medical treatment of depression, 1991–1996: Productive inefficiency, expected outcome variations and price indexes, Journal of Health Economics, 21, 373, 10.1016/S0167-6296(01)00132-1 Berndt, E. R., Busch, S. H., & Frank, R. G. (2001). Treatment price indexes for acute phase major depression. In D. M. Cutler & E. R. Berndt (Eds.), Medical care output and productivity. Studies in income and wealth (Vol. 61, pp. 463–505). Chicago: University of Chicago Press for the National Bureau of Economic Research. Berndt, E. R., Cockburn, I. M., & Griliches, Z. (1996). Pharmaceutical innovations and market dynamics: Tracking effects on price indexes of antidepressant drugs. Brookings papers on economic activity: Microeconomics (pp. 133–188). Berndt, E. R., Cutler, D. M., Frank, R. G., Newhouse, J. E., & Triplett, J. E. (2000). Medical care prices and output. In A. Culyer & J. E. Newhouse (Eds.), Handbook of health economics (pp. 119–180). Amsterdam: Elsevier. Berndt, 2001, Price and quality of desktop and mobile personal computers: A quarter century historical overview, American Economic Review, 91, 168, 10.1257/aer.91.2.268 Blazer, 2000, Marked differences in antidepressant use by race in an elderly community sample: 1986–1996, American Journal of Psychiatry, 157, 1089, 10.1176/appi.ajp.157.7.1089 Busch, A. B., Frank, R. G., & Lehman, A. F. (in press). The effect of a managed behavioral health care carve-out on quality of care for medicaid patients diagnosed with schizophrenia. Archives of General Psychiatry. Busch, 2002, Specialty health care, treatment patterns and quality: The impact of a mental health carve-out on care for depression, Health Services Research, 37, 1583, 10.1111/1475-6773.11092 Croghan, 1998, Cost-effectiveness of antidepressant medications, Journal of Mental Health Policy and Economics, 1, 109, 10.1002/(SICI)1099-176X(1998100)1:3<109::AID-MHP15>3.0.CO;2-2 Diewert, 1992, Fisher ideal output, Journal of Productivity Analysis, 3, 211, 10.1007/BF00158354 Diewert, W. E. (1993). The economic theory of index numbers: A survey. In W. Erwin Diewert & A. O. Nakamura (Eds.), Essays in index number theory (Chap. 7, Vol. 1, pp. 177–221). London: North-Holland. Duan, 1983, Smearing estimate: A nonparametric retransformation method, Journal of the American Statistical Association, 78, 605, 10.2307/2288126 Duggan, M. G. (2003, April). Does medicaid pay too much for prescription drugs? A case study of atypcial anti-psychotics (Working Paper No. 9626). Cambridge, MA: National Bureau of Economic Research. F-D-C Reports. (2003, September 22). FDA sides with Lilly: Seeks class warning on antipsychotic diabetes risk. The Pink Sheet, 65(38), 26–28. Frank, R. G., & Conti, R. (2003, January 24). Mental health policy and psychotropic drugs. Issue paper prepared for the Sub-Committee on Psychiatric Medications of the President’s Mental Health Commission. Geiger-Brown, J. (2002). The concordance of medicaid claims, survey and research diagnoses for patients with serious and persistent mental illness. Department of Psychiatry, University of Maryland. Glied, S., & Frank R. G. (2004). Better but not well. Unpublished manuscript, Harvard/Columbia Universities. Hafner, H., Maurer, K., Loffler, W., Fatkenheuer, B., van der Heiden, W., Riecher-Rossler, S., et al. (1994, April). The epidemiology of early schizophrenia: Influence of age and gender on onset and early course. British Journal of Psychiatry, 23, 29–38. Lehman, 1999, Quality of care in mental health: The case of Schizophrenia, Health Affairs, 18, 52, 10.1377/hlthaff.18.5.52 Lehman, A. F. & Steinwachs, D. M., and the Co-Investigators of the PORT Project (1998a). Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24(1), 1–10. Lehman, A. F., Steinwachs, D. M., and the Survey Co-Investigators of the PORT Project (1998b). Patterns of usual care for schizophrenia: Initial results from the schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophrenia Bulletin, 24(1), 11–20. Ling, D. Y. C., Berndt, E. R., & Frank, R. G., (2003, June). General purpose technologies, technology-skill complementarity, and the diffusion of new psychotropic drugs among medicaid populations. Unpublished manuscript, Harvard Medical School, Boston, MA. Ling, D. Y. C., Busch, A. B., Frank, R. G., & Pakes, J. (2002, September 24). Treatment price indexes for bipolar disorder. Poster presented at NIMH Economics of Mental Health Workshop, Bethesda, MD. Ling, D. Y. C., Frank, R. G., & Berndt, E. R. (2003, March). Behavioral health carve-outs and psychotropic drug spending in medicaid populations. Unpublished manuscript, Division of Health Care Policy, Harvard Medical School, Boston, MA. Lurie, N., Popkin, M., Dysken, M., Moscovice, I., Finch, M. (1992). Accuracy of diagnoses of schizophrenia in medicaid claims. Hospital and Community Psychiatry, 43(1), 69–71. Melfi, 2000, Racial variation in antidepressant treatment in a medicaid population, Journal of Clinical Psychiatry, 61, 16, 10.4088/JCP.v61n0105 Merck Medical Manual of Medical Information. (1997). Home edition. Whitehouse Station, NJ: Merck Research Laboratories. National Academy of Sciences. (2002). At what price? conceptualizing and measuring the cost-of-living and price indexes. In C. Schultze & C. Mackie (Eds.), Panel on conceptual, measurement and other statistical issues in developing cost-of-living indexes (332 pp.). Committee on National Statistics, National Research Council. Rupp, 1993, The costs of schizophrenia: Assessing the burden, Psychiatric Clinics of North America, 160, 413, 10.1016/S0193-953X(18)30182-5 Shern, D. L. (2000). Evaluation of Florida’s prepaid mental health plan: Year 3 report. Tampa: University of South Florida. Shern, D. L. (2001). Evaluation of Florida’s prepaid mental health plan: Year 4 report, 2001. Tampa: Louis de la Parte Florida Mental Health Institute, University of South Florida. Snowden, 2000, Medicaid and African American outpatient mental health treatment, Mental Health Services Research, 2, 115, 10.1023/A:1010161222515 Triplett, 1992, Economic Theory of BEA’s alternative quantity and price indexes, Survey of Current Business, 72, 49 Triplett, J. E. (2001). What’s different about health? Human repair and car repair in the national accounts. In D. M. Cutler & E. R. Berndt (Eds.), Medical output and productivity (pp. 15–94). Chicago: University of Chicago Press for the National Bureau of Economic Research. Wells, K., Sturm, R. M., & Sherbourne, C., Meredith, L. (1996). Caring for depression: A RAND study. Cambridge, MA: Harvard University Press.